Department of Pharmacology, Weill Cornell Medical College, New York, New York 10065, USA.
J Biol Chem. 2013 Jul 26;288(30):21514-25. doi: 10.1074/jbc.M113.458067. Epub 2013 Jun 14.
Effects of the environmental toxin and carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) include a wasting syndrome associated with decreased gluconeogenesis. TCDD is a potent activator of the aryl hydrocarbon receptor (AHR), a ligand activated transcription factor. The relationship between gene activation by the AHR and TCDD toxicities is not well understood. We recently identified a pathway by which the AHR target gene TiPARP (TCDD-inducible poly(ADP-ribose) polymerase) contributes to TCDD suppression of transcription of phosphoenolpyruvate carboxykinase (PEPCK), a key regulator of gluconeogenesis, by consuming NAD(+) and decreasing Sirtuin 1 activation of the peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α), a transcriptional activator of PEPCK. We report here that TCDD-induced TiPARP also targets PEPCK for ADP-ribosylation. Both cytosolic and mitochondrial forms of PEPCK were found to undergo ADP-ribosylation. Unexpectedly, AHR suppression also enhanced ADP-ribosylation and did so by a poly(ADP-ribose) polymerase-independent mechanism. This report 1) identifies ADP-ribosylation as a new posttranslational modification for PEPCK, 2) describes a pathway by which transcriptional induction of TiPARP by the AHR can lead to a downstream posttranslational change in a TCDD target protein (PEPCK), and 3) reveals that the AHR exerts complex, previously unidentified modulatory effects on ADP-ribosylation.
环境毒素和致癌物 2,3,7,8-四氯二苯并对二恶英(TCDD,二恶英)的影响包括与糖异生减少相关的消耗综合征。TCDD 是芳烃受体(AHR)的有效激活剂,AHR 是一种配体激活的转录因子。AHR 基因激活与 TCDD 毒性之间的关系尚不清楚。我们最近确定了一条途径,通过该途径,AHR 靶基因 TiPARP(TCDD 诱导的多聚(ADP-核糖)聚合酶)通过消耗 NAD+和降低 Sirtuin 1 对过氧化物酶体增殖物激活受体 γ共激活因子 1α(PGC1α)的激活来促进 TCDD 抑制磷酸烯醇丙酮酸羧激酶(PEPCK)的转录,PEPCK 是糖异生的关键调节剂。我们在这里报告,TCDD 诱导的 TiPARP 也将 PEPCK 作为 ADP-核糖基化的靶标。发现细胞质和线粒体形式的 PEPCK 都发生 ADP-核糖基化。出乎意料的是,AHR 抑制也增强了 ADP-核糖基化,并且是通过一种与多聚(ADP-核糖)聚合酶无关的机制。本报告 1)确定 ADP-核糖基化为 PEPCK 的一种新的翻译后修饰,2)描述了 AHR 通过诱导 TiPARP 的转录可导致 TCDD 靶蛋白(PEPCK)的下游翻译后变化的途径,3)揭示了 AHR 对 ADP-核糖基化产生复杂的、以前未识别的调节作用。